SCHEMBL9154699

SCHEMBL9154699

O=C1CCC(CO)N1C(=O)Nc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 2/20 0.48
TPSD1 Q9BZJ3 2/20 0.48
TPSG1 Q9NRR2 2/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 3/20 0.47
GAA P10253 2/20 0.47
KDM4E B2RXH2 2/20 0.47
TSHR P16473 1/20 0.47
ITGB1 P05556 3/20 0.46
ITGA4 P13612 1/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
FAAH O00519 1/20 0.45
HTT P42858 1/20 0.43
POLB P06746 1/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
TP53 P04637 3/20 0.43
ITGA5 P08648 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9153055 0.77 L3MBTL1 (0.42) TPSAB1TPSD1TPSG1SMN1; SMN2ALDH1A1
SCHEMBL11499414 0.76 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1GAAKDM4ETSHR
SCHEMBL6233244 0.76 ACE (0.38) ITGB1ITGA4POLB
SCHEMBL3182376 0.76 ACE (0.38) ITGB1ITGA4POLB
SCHEMBL3182383 0.76 ACE (0.38) ITGB1ITGA4POLB
SCHEMBL21427791 0.75 ALDH1A1 (0.54) ALDH1A1KMT2ANPC1PKMCYP2C9
SCHEMBL21408809 0.75 ALDH1A1 (0.54) ALDH1A1KMT2ANPC1PKMCYP2C9
SCHEMBL18447374 0.74 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1GAAKDM4ETSHR
SCHEMBL11719448 0.73 KMT2A (0.70) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL14879565 0.73 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5447944-A Activating cerebral metabolism and protection against anoxic brain damage TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-09-05 US disclosed
EP-0373226-B1 Carbamoyl-2-pyrrolidinone compounds TAIHO PHARMACEUTICAL CO LTD (JP) 1994-06-15 EP disclosed
US-5229402-A Improving cerebral function TAIHO PHARMACEUTICAL COMPANY, LTD. (JP) 1993-07-20 US disclosed
EP-0373226-A1 Carbamoyl-2-pyrrolidinone compounds TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1990-06-20 EP disclosed